“Comparative Study Between Combination Therapy Empagliflozin–Sitagliptin and Empagliflozin–Alogliptin in Addition to Metformin Assessing the Hypoglycemic Effect on Patients Diagnosed With Malignancy and Poorly Controlled Type 2 Diabetes Mellitus As Comorbidity”. Journal of Carcinogenesis 24, no. 3 (September 23, 2025): 669–674. Accessed December 6, 2025. https://carcinogenesis.com/index.php/JOC/article/view/1025.